A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder

Alcohol use disorder (AUD) is associated with microbial alterations that worsen with cirrhosis. Fecal microbiota transplant (FMT) could be a promising approach.

[1]  Keir Martin Dependence , 2021, Cambridge Encyclopedia of Anthropology.

[2]  D. Brenner,et al.  Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder , 2020, Frontiers in Physiology.

[3]  R. Frozza,et al.  The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication , 2020, Frontiers in Endocrinology.

[4]  S. Taylor-Robinson,et al.  Microbial Functional Change is Linked with Clinical Outcomes after Capsular Fecal Transplant in Cirrhosis. , 2019, JCI insight.

[5]  M. Osman,et al.  Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial , 2019, Hepatology.

[6]  Miriam H. Huntley,et al.  Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. , 2019, The New England journal of medicine.

[7]  M. Osman,et al.  Donor Screening for Fecal Microbiota Transplantation. , 2019, The New England journal of medicine.

[8]  N. Bray The microbiota–gut–brain axis , 2019 .

[9]  K. Faber,et al.  Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases , 2019, Front. Immunol..

[10]  N. Delzenne,et al.  The gut microbiota: A new target in the management of alcohol dependence? , 2019, Alcohol.

[11]  S. Sarin,et al.  Microbiome as a therapeutic target in alcohol-related liver disease. , 2019, Journal of hepatology.

[12]  J. Bajaj,et al.  Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis. , 2019, Gastroenterology.

[13]  J. Bajaj Alcohol, liver disease and the gut microbiota , 2019, Nature Reviews Gastroenterology & Hepatology.

[14]  Lanjuan Li,et al.  Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study , 2018, Front. Microbiol..

[15]  Xiaoli Wu,et al.  Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis , 2018, Front. Integr. Neurosci..

[16]  G. Szabo Women and alcoholic liver disease — warning of a silent danger , 2018, Nature Reviews Gastroenterology & Hepatology.

[17]  S. Taylor-Robinson,et al.  Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial , 2017, Hepatology.

[18]  Dmitry S. Ischenko,et al.  Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease , 2017, Microbiome.

[19]  S. Sarin,et al.  Healthy Donor Fecal Microbiota Transplantation in Steroid‐Ineligible Severe Alcoholic Hepatitis: A Pilot Study , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  N M Delzenne,et al.  The link between inflammation, bugs, the intestine and the brain in alcohol dependence , 2017, Translational Psychiatry.

[21]  M. Dekker Nitert,et al.  Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy , 2016, Hypertension.

[22]  R. Bataller,et al.  Biomarkers for monitoring alcohol use , 2016, Clinical liver disease.

[23]  G. Addolorato,et al.  Treatment of alcohol use disorders in patients with alcoholic liver disease. , 2016, Journal of hepatology.

[24]  E. Elinav,et al.  Metabolites: messengers between the microbiota and the immune system , 2016, Genes & development.

[25]  J. Bajaj,et al.  Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study , 2016, The American Journal of Gastroenterology.

[26]  E. Le Chatelier,et al.  Qin et al. reply , 2015, Nature.

[27]  R. Mattick,et al.  Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis. , 2014, Drug and alcohol dependence.

[28]  Sébastien Matamoros,et al.  Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity , 2014, Proceedings of the National Academy of Sciences.

[29]  Philip Wong,et al.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver , 2014, Hepatology.

[30]  Jürgen Rehm,et al.  Global burden of alcoholic liver diseases. , 2013, Journal of hepatology.

[31]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[32]  G. Nava,et al.  Diversity of the autochthonous colonic microbiota , 2011, Gut microbes.

[33]  N. Ren,et al.  Ethanoligenens harbinense gen. nov., sp. nov., isolated from molasses wastewater. , 2006, International journal of systematic and evolutionary microbiology.

[34]  K Weissenborn,et al.  Neuropsychological characterization of hepatic encephalopathy. , 2001, Journal of hepatology.

[35]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.

[36]  K. Nelson,et al.  Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. , 2015, Gastroenterology.

[37]  J. Westermeyer,et al.  Alcohol craving in outpatients with alcohol dependence: rate and clinical correlates. , 2006, Journal of studies on alcohol.